Veklury® (Remdesivir)

COVID-19 Therapy (Severe)

NDA Acceptance

Exp Date


Amp Volatility Score

Catalyst Info & Data Links

Updated by HC

#GILD, #Remdesivir , #COVID19

Prior Data (click to view full image)


Trial Design / Revenue (click to view full image)


Recent Posts

See What The Community Is Saying - Click To See Full Post

GILD - Submits New Drug Applic...

Gilead Sciences, Inc. (Nasdaq: #GILD) announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for #Veklury®(#remdesivir), an investigational antivir...

*Disclaimer: Information provided on and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon